| Tag | Content |
|---|
EnhancerAtlas ID | HS105-84066 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chrX:1600290-1601320 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEOX1 | MA0661.1 | chrX:1601158-1601168 | GCTAATTAAC | + | 6.02 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_09748 | chrX:1599661-1601729 | CD14 | | SE_10317 | chrX:1600012-1601515 | CD19_Primary | | SE_11269 | chrX:1597450-1603818 | CD20 | | SE_12201 | chrX:1598342-1601632 | CD3 | | SE_16610 | chrX:1599473-1601769 | CD4_Naive_Primary_8pool | | SE_18552 | chrX:1598078-1603697 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_20171 | chrX:1597547-1601775 | CD56 | | SE_22596 | chrX:1596285-1601637 | CD8_primiary | | SE_32559 | chrX:1598504-1601682 | GM12878 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH0XI001480 | chrX | 1599695 | 1601493 |
|
Enhancer Sequence | AGGTGATCCA CCTGCCTCGA CCTCCCAAAG TGCTGGGATT ACAGGCGTGA GCCACCGTGC 60
CCGGCCAGGT AGTCACATTT TCTTCAAGCT TTGGGTTTAA GGGATCCCAG CTTTGGGCTT 120
AAGGGATCCC AGCTTTGGGT TTAAGGAGCC CAGCTTTGGG TTTAGGAGAG TCCAGCTTTG 180
GGATTAGGAG AGTCCAGCTT TGGGATTAGG AGAGTCCAGC TTTGGGATTA GGAGAGTCCA 240
GCTTTGGGTT TAGTGGAGCT CAGCTTCCAA CCCTCGCACC CTCAAAGTTC CCCATCTTTG 300
TAGACCCAGT GACCCCTGTT TCTGTGATAA CACCTGCCTC TGAACGAACT CTGTGTTCTA 360
CTGACTTCAA AGTGACCCAC CAGCCCCAGT GAACTGGCAG CTGGCAGGCG TCAGGGGATA 420
GAGGACCTGC TGGCGTCGGC CTCAGATCAC AAGGCAAGAA TCCTCCTAGC TAAGCACAAA 480
AACGCGTAGG AAATGCTCTG AGCTCTGCCG CTGTGTGTTG ATTTTCCTGT ATTGCATCAC 540
CCAACGAAGC AGACCGTTTG CCCAGCGAGA TTTGCATGCT GTCCTCCGCA GACGCCCCGT 600
GGAGATTTTG ATCTGCGTCT TCTGCAAAGG CAGCGGCCGC GTTTCTCTGA TTTCTGTATC 660
TCATTCTCAG AGTATATAGC ACGGGGCTTC ATCGCTGGCC AGAGAGCAGA TTCTGAGAAA 720
CATAAGAAGC CCCTTTTTGA AACAAAATTA ATTTGTGTGT GTGGTGTGTG TGTGTGTGTG 780
TGTGTGTGTG TGTATGGGTG AGGATGTCTC AACAGCAGCA AAATCGGCCT CACTCTGGAA 840
GGCAGGAAGC CACTGTACGT GGAATTAAGC TAATTAACAT GAAATGCCAT TTGGTGAAAA 900
AAAAAAAAAA AACCCAAAGT GGTTGAGTGT GTGGCTCCTG CCCTGCTGCA AAAGAAGAGT 960
GTGGAAATAG CACGTATGCT GAAATTTAAG CACTTCTGCC GTTACTGAGC CACAGTGCCC 1020
ATGGTTTTAG 1030
|
